tm logo
IDACIO
Live/Registered
REGISTERED

on 26 Sep 2023

Last Applicant/ Owned by

Else-Kroener-Str. 1

Bad Homburg

DE

61352

Serial Number

97373891 filed on 21st Apr 2022

Registration Number

7177855 registered on 26th Sep 2023

in the Principal Register

Correspondent Address

Scott D. Woldow

Scott D. Woldow

1055 THOMAS JEFFERSON ST, NW, SUITE 400

WASHINGTON, DC 20007

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

IDACIO

Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Pharmaceutical preparations, namely, immunosuppressants; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treat Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Pharmaceutical preparations, namely, immunosuppressants; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and active enthesitis related arthritis, Crohn's disease, ulcerative colitis, hidradenitis colitis, hidradenitis suppurativa and non-infectious uveitis; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Biologics, namely, biological preparations for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Biologics, namely, biological preparations for the treatment of ankylosing spondylitis; Biological preparations for the treatment of and reducing signs and symptoms in adult patients with active ankylosing spondylitis; Protein therapeutics, namely, protein supplements; Pharmaceutical preparations for treating ankylosing spondylitis; Pharmaceutical preparations for the treatment of and for reducing signs and symptoms in adult patients with active ankylosing spondylitis; Pharmaceutical preparations for treating a wide variety of autoimmune diseases, illnesses and conditions


First Use Date in General

01st Jul 2023

First Use Date in Commerce

01st Jul 2023

Mark Details


Serial Number

No 97373891

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 034175.077C

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
26th Sep 2023REGISTERED-PRINCIPAL REGISTER
26th Sep 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
22nd Aug 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21st Aug 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02th Aug 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
02th Aug 2023STATEMENT OF USE PROCESSING COMPLETE
14th Jul 2023TEAS STATEMENT OF USE RECEIVED
14th Jul 2023USE AMENDMENT FILED
17th Jan 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22nd Nov 2022PUBLISHED FOR OPPOSITION